1. 342PResponse to primary treatment for first recurrence independently influences survival of patients with hormone receptor-positive, HER2-negative breast cancer: A multicenter study of 236 recurrent metastatic patients. (23rd October 2018) Authors: Yamamura, J; Kamigaki, S; Tsujie, M; Fujita, J; Osato, H; Higashi, C; Kanaizumi, H; Tanaka, Y; Hamada, M; Shinzaki, W; Hasimoto, Y; Komoike, Y Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗